Form 4 Tracker
UNITED THERAPEUTICS Corp
UTHR

210 insider filings · Latest: Aug 14, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Mar 16, 2026Mar 16 10:03 PMJUDY OLIAN
Proposed Sale
200$535.44$107.1K

View →

Mar 16, 2026Mar 16 8:31 PMJudy D. OlianDirector
Sale
200$535.44$107.1K4,445(D)

View →

Mar 13, 2026Mar 16 8:30 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$538.00$5.1M130(D)

View →

Mar 16, 2026Mar 16 12:30 PMMartine A RothblattDirector, Chairperson & CEO
Sale
516$534.99$276.1K8,414(D)

View →

Mar 12, 2026Mar 16 12:30 PMMartine A RothblattDirector, Chairperson & CEO
Sale
8,984$537.97$4.8M130(D)

View →

Mar 11, 2026Mar 11 11:31 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$539.54$5.1M130(D)

View →

Mar 10, 2026Mar 11 8:30 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$539.71$5.1M130(D)

View →

Mar 9, 2026Mar 10 8:34 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$518.03$4.9M130(D)

View →

Mar 6, 2026Mar 10 8:33 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$477.67$4.5M130(D)

View →

Mar 6, 2026Mar 9 8:36 PMJudy D. OlianDirector
Sale
200$510.00$102.0K4,645(D)

View →

Mar 5, 2026Mar 9 8:36 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$484.55$4.6M130(D)

View →

Mar 9, 2026Mar 9 8:04 PMJUDY OLIAN
Proposed Sale
200$510.00$102.0K

View →

Mar 5, 2026Mar 5 9:37 PMPaul A MahonEVP & GENERAL COUNSEL
Sale
8,300$483.16$4.0M36,844(D)

View →

Mar 4, 2026Mar 5 9:36 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$146.03$1.4M9,630(D)

View →

Mar 4, 2026Mar 5 9:36 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$489.91$4.7M130(D)

View →

Mar 4, 2026Mar 5 9:36 PMRay KurzweilDirector
Sale
4,910$489.02$2.4M12,670(D)

View →

Mar 4, 2026Mar 5 9:35 PMTommy G ThompsonDirector
Sale
2,000$489.42$978.8K8,480(D)

View →

Mar 4, 2026Mar 5 9:34 PMChristopher CauseyDirector
Sale
20$490.17$9.8K4,190(D)

View →

Mar 3, 2026Mar 5 9:33 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$499.42$4.7M130(D)

View →

Mar 5, 2026Mar 5 9:03 PMPAUL MAHON
Proposed Sale
8,300$483.16$4.0M

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jan 20, 2026Jan 28 9:31 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
7,875$146.0336,565(I)

View →

Jan 20, 2026Jan 28 9:30 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
14,625$146.0367,875(I)

View →

Jan 21, 2026Jan 23 9:32 PMKevin TraceyDirector
Grant/Award
1,2201,220(D)

View →

← Previous

Page 11 of 11